Contract 75H71221A00014
Roche Diabetes Care Inc · Department Of Health And Human Services · September 23, 2021
Roche Diabetes Care Inc was awarded a federal contract by Department Of Health And Human Services (Indian Health Service) on September 23, 2021 for an undisclosed amount of work in in-vitro diagnostic substance manufacturing. This is a task or delivery order issued under parent IDIQ V797D50597. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $2.00 million.
Contract details
- PIID
- 75H71221A00014
- Parent IDIQ
- V797D50597
- Award type
- —
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Medical And Surgical Instruments, Equipment, And Supplies
- First action
- September 23, 2021
Description
ROCHE BPA, PIMC
Modification timeline
-
September 23, 2021Base award$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75H71221A00014?
Contract 75H71221A00014 is a federal contract awarded to Roche Diabetes Care Inc by Department Of Health And Human Services on September 23, 2021 for an undisclosed amount of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75H71221A00014?
Roche Diabetes Care Inc won contract 75H71221A00014 from Department Of Health And Human Services.
How much is contract 75H71221A00014 worth?
Contract 75H71221A00014 has obligated $0 to date but carries a potential ceiling of $2.00 million if fully funded and all options are exercised.